No Priors AI GOP Presses RFK Jr on Mifepristone Review
Nov 21, 2025
Republicans push HHS Secretary RFK Jr. to tighten regulations on mifepristone, aiming to reshape access and influence telehealth rules. Kennedy raises concerns about a hidden safety signal, prompting a request for a comprehensive FDA review. Over 50 GOP senators demand in-person dispensing and limit telehealth options, presenting a pivotal moment for anti-abortion conservatives. The potential consequences could restrict access and increase costs, setting the stage for key political tensions.
AI Snips
Chapters
Transcript
Episode notes
GOP Sees Review As Reversal Opportunity
- Republicans view RFK Jr.'s review as a chance to reverse Biden-era liberalization of mifepristone.
- They aim to tighten oversight, restore stricter protocols, and limit telehealth access to reshape access.
Kennedy Claims Hidden Safety Signal
- RFK Jr. accused the prior administration of twisting mifepristone data and claimed a buried safety signal.
- He asked FDA Commissioner Marty Macari for a top-to-bottom review to ensure transparent, science-first decisions.
GOP Demands Specific Regulatory Steps
- GOP senators demanded reinstating in-person dispensing, limiting telemedicine, and halting generic approvals pending review.
- These steps aim to reduce remote access and pause price-competition until the review concludes.